Scientists test re-engineered immune cells to fight severe lupus
NCT ID NCT06150651
Summary
This early-stage study tested the safety of a new cell therapy for adults with severe, hard-to-treat lupus. Doctors collected patients' own immune cells, genetically modified them to target lupus-causing B cells, and then infused them back. The main goal was to see if this experimental treatment was safe and to check for any early signs it might help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE (SYSTEMIC LUPUS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
King Chulalongkorn Memorial Hospital
Bangkok, Please Select, 10330, Thailand
Conditions
Explore the condition pages connected to this study.